US Patent 7622445 Muteins of fibroblast growth factor 21
Patent 7622445 was granted and assigned to Eli Lilly and Company on November, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+483 characters)
Article
Patent abstract
The present invention relates to novel muteins of human fibroblast growth factor-21 with reduced susceptibility for proteolytic degradation when expressed in yeast. Both protein and the respective encoding nucleic acid species are disclosed. The invention also embodies vectors and host cells for the propagation of said nucleic acid sequences and the production of said muteins. Also disclosed are methods for treating type 2 diabetes, obesity, or metabolic syndrome.
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07622445 Muteins of fibroblast growth factor 21 US Patent 7622445 Muteins of fibroblast growth factor 21
Infobox
Patent Number
0762244500
Patent Number
762244500
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076224450
Date of Patent
November 24, 2009
0Patent Application Number
115719330
Date Filed
August 25, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076224450
Date of Patent
November 24, 2009
0Patent Application Number
115719330
Date Filed
August 25, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07622445 Muteins of fibroblast growth factor 21
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07622445
Date of patent
November 24, 2009
Patent application number
11571933
Date Filed
August 25, 2005
Patent primary examiner
Find more entities like US Patent 7622445 Muteins of fibroblast growth factor 21
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
